IVP · Inspire Veterinary Partners, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | $4.49M | $4.83M | - | $2.92M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - |
| SG&A | $2.42M | $2.65M | $2.45M | - | $2.99M | $2.22M | $2.87M | - | $3.56M |
| Total Operating Expenses | $6.28M | $6.90M | $5.65M | - | $6.28M | $5.42M | $7.69M | - | $6.95M |
| D&A | $330.5K | $252.3K | $275.4K | - | $340.2K | $340.9K | $347.4K | - | $313.3K |
| Operating Income | ($1.97M) | ($2.62M) | ($2.01M) | - | ($2.24M) | ($933.0K) | ($2.86M) | - | ($2.83M) |
| Interest Expense | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - |
| Net Income | ($2.53M) | ($3.03M) | ($2.42M) | - | ($3.49M) | ($3.39M) | ($3.42M) | - | ($7.88M) |
| EPS - Basic | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $576.2K | $393.4K | $1.86M | $523.7K | $681.2K | $7.7K | $69.1K | $179.0K | $1.96M |
| Accounts Receivable | $28.7K | $183.6K | $4.4K | $40.7K | $115.6K | $39.7K | $341.5K | $28.6K | $241.6K |
| Inventory | $497.6K | $477.0K | $475.2K | $516.6K | $563.6K | $574.6K | $545.7K | $571.5K | $680.3K |
| Accounts Payable | $1.70M | $1.88M | $1.77M | $1.98M | $2.07M | $3.72M | $3.52M | $3.21M | $2.30M |
| Current Assets | $3.82M | $1.33M | $2.90M | $2.02M | $4.45M | $2.20M | $3.14M | $1.35M | $3.54M |
| Total Assets | $23.96M | $20.81M | $20.66M | $20.20M | $22.40M | $21.93M | $23.40M | $21.79M | $21.30M |
| Current Liabilities | $9.72M | $10.05M | $7.47M | $8.20M | $7.03M | $12.41M | $8.45M | $7.58M | $5.09M |
| Long-term Debt | $11.76M | $12.03M | $11.52M | $11.98M | $12.43M | $14.60M | - | - | - |
| Total Liabilities | $19.79M | $20.36M | $17.66M | $18.63M | $19.37M | $25.04M | $23.13M | $22.58M | $25.32M |
| Stockholders' Equity | $4.17M | $1.56M | $3.00M | $1.56M | $3.03M | ($3.11M) | $269.9K | ($788.3K) | ($3.61M) |
| Retained Earnings | ($44.33M) | ($41.80M) | ($38.77M) | ($36.35M) | ($31.73M) | ($28.24M) | ($24.85M) | ($21.22M) | ($16.89M) |
Cash Flow
| Line item | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($1.37M) | - | - | - | ($3.17M) | - | - |
| Investing Cash Flow | - | - | ($20.3K) | - | - | - | ($156.9K) | - | - |
| Financing Cash Flow | - | - | $2.53M | - | - | - | $3.22M | - | - |
| CapEx | - | - | $20.3K | - | - | - | $156.9K | - | - |
| Free Cash Flow | - | - | ($1.39M) | - | - | - | ($3.33M) | - | - |
Ratios
| Metric | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 |
|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||
| Gross margin | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | -20.8% | -59.2% | - | -96.8% |
| EBITDA margin | - | - | - | - | - | -13.2% | -52.1% | - | -86.1% |
| Net margin | - | - | - | - | - | -75.4% | -70.8% | - | -269.6% |
| Free cash flow margin | - | - | - | - | - | - | -68.8% | - | - |
| FCF / Net income | - | - | 0.58 | - | - | - | 0.97 | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | 49.4% | 59.5% | - | 121.8% |
| Effective tax rate | - | - | - | - | - | - | - | - | - |
| Return on assets | -10.5% | -14.6% | -11.7% | - | -15.6% | -15.4% | -14.6% | - | -37.0% |
| Return on equity | -60.6% | -194.3% | -80.4% | - | -115.2% | 108.7% | -1268.0% | - | 218.3% |
| Return on invested capital | - | - | - | - | - | - | - | - | - |
| Liquidity | |||||||||
| Current ratio | 0.39 | 0.13 | 0.39 | 0.25 | 0.63 | 0.18 | 0.37 | 0.18 | 0.69 |
| Quick ratio | 0.34 | 0.09 | 0.32 | 0.18 | 0.55 | 0.13 | 0.31 | 0.10 | 0.56 |
| Cash ratio | 0.06 | 0.04 | 0.25 | 0.06 | 0.10 | 0.00 | 0.01 | 0.02 | 0.38 |
| Leverage | |||||||||
| Debt / Equity | 2.82 | 7.70 | 3.84 | 7.67 | 4.10 | -4.69 | - | - | - |
| Debt / Assets | 0.49 | 0.58 | 0.56 | 0.59 | 0.55 | 0.67 | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 5.75 | 13.32 | 6.88 | 12.93 | 7.39 | -7.04 | 86.70 | -27.64 | -5.90 |
| Liabilities / Assets | 0.83 | 0.98 | 0.85 | 0.92 | 0.86 | 1.14 | 0.99 | 1.04 | 1.19 |
| Efficiency | |||||||||
| Asset turnover | - | - | - | - | - | 0.20 | 0.21 | - | 0.14 |
| Inventory turnover | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | 3d | 26d | - | 30d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - |
| Valuation | |||||||||
| P / E | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - |
| Growth | |||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 12.0% | -180.3% | 29.9% | - | 21.1% | - | - | - | - |
| Net income growth (YoY) | 27.6% | 10.4% | 29.4% | - | 55.7% | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | 58.1% | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 37.6% | - | 1013.2% | - | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Product / service
$16.68M totalService$11.88M · 71.2%
Product$4.80M · 28.8%
Peer comparison
Same SIC group: Agricultural Services
Comparing INSPIRE VETERINARY PARTNERS against the 5 most active filers in the same SIC group.